Special: CDMO Landscape Europe

The European CDMO market is expanding at 7–7.6% CAGR, with valuations clustering around €35–€42 billion in 2025–2026 and forecasts reaching €60–€89 billion by 2034–2035. Germany leads with 30% market share, while France is the fastest-growing market, driven by €1.87 billion in pharmaceutical investment for manufacturing capacity.

In this Special:

• How Europe’s external manufacturing ecosystem is evolving
• The European CDMO Model, Powering Biologics Innovation
• Mitigating regulatory risk with holistic CMC strategies